[HTML][HTML] Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
Despite the considerable efficacy observed when targeting a dispensable lineage antigen,
such as CD19 in B cell acute lymphoblastic leukaemia,, the broader applicability of adoptive …
such as CD19 in B cell acute lymphoblastic leukaemia,, the broader applicability of adoptive …
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia.
G Casirati, A Cosentino, A Mucci, U Zabala, J Zeng… - Nature, 2023 - europepmc.org
Despite the considerable efficacy observed when targeting a dispensable lineage antigen,
such as CD19 in B cell acute lymphoblastic leukaemia 1, 2, the broader applicability of …
such as CD19 in B cell acute lymphoblastic leukaemia 1, 2, the broader applicability of …
[HTML][HTML] Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
G Casirati, A Cosentino, A Mucci, MS Mahmoud… - Nature, 2023 - ncbi.nlm.nih.gov
Despite the considerable efficacy observed when targeting a dispensable lineage antigen,
such as CD19 in B cell acute lymphoblastic leukaemia 1, 2, the broader applicability of …
such as CD19 in B cell acute lymphoblastic leukaemia 1, 2, the broader applicability of …
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
G Casirati, A Cosentino, A Mucci, MS Mahmoud… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Despite the considerable efficacy observed when targeting a dispensable lineage antigen,
such as CD19 in B cell acute lymphoblastic leukaemia 1, 2, the broader applicability of …
such as CD19 in B cell acute lymphoblastic leukaemia 1, 2, the broader applicability of …
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
G Casirati, A Cosentino, A Mucci… - …, 2023 - ui.adsabs.harvard.edu
Despite the considerable efficacy observed when targeting a dispensable lineage antigen,
such as CD19 in B cell acute lymphoblastic leukaemia 1, 2, the broader applicability of …
such as CD19 in B cell acute lymphoblastic leukaemia 1, 2, the broader applicability of …
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
G Casirati, A Cosentino, A Mucci, MS Mahmoud… - Nature, 2023 - ideas.repec.org
Despite the considerable efficacy observed when targeting a dispensable lineage antigen,
such as CD19 in B cell acute lymphoblastic leukaemia1, 2, the broader applicability of …
such as CD19 in B cell acute lymphoblastic leukaemia1, 2, the broader applicability of …
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
G Casirati, A Cosentino, A Mucci, M Salah Mahmoud… - Nature, 2023 - archive.jibiology.com
Despite the considerable efficacy observed when targeting a dispensable lineage antigen,
such as CD19 in B cell acute lymphoblastic leukaemia1, 2, the broader applicability of …
such as CD19 in B cell acute lymphoblastic leukaemia1, 2, the broader applicability of …
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
G Casirati, A Cosentino, A Mucci, M Salah Mahmoud… - paper.sciencenet.cn
Despite the considerable efficacy observed when targeting a dispensable lineage antigen,
such as CD19 in B cell acute lymphoblastic leukaemia1, 2, the broader applicability of …
such as CD19 in B cell acute lymphoblastic leukaemia1, 2, the broader applicability of …
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
G Casirati, A Cosentino, A Mucci, MS Mahmoud… - Nature, 2023 - econpapers.repec.org
Despite the considerable efficacy observed when targeting a dispensable lineage antigen,
such as CD19 in B cell acute lymphoblastic leukaemia1, 2, the broader applicability of …
such as CD19 in B cell acute lymphoblastic leukaemia1, 2, the broader applicability of …
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia.
G Casirati, A Cosentino, A Mucci, U Zabala, J Zeng… - Nature, 2023 - europepmc.org
Despite the considerable efficacy observed when targeting a dispensable lineage antigen,
such as CD19 in B cell acute lymphoblastic leukaemia 1, 2, the broader applicability of …
such as CD19 in B cell acute lymphoblastic leukaemia 1, 2, the broader applicability of …